KEANE WILLIAM P 4
4 · SALIX PHARMACEUTICALS LTD · Filed Jun 7, 2012
Insider Transaction Report
Form 4
KEANE WILLIAM P
Director
Transactions
- Sale
Common Stock
2012-06-05$51.67/sh−10,000$516,692→ 33,202 total
Holdings
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 30,000
Option to Buy Common Stock
Exercise: $15.25Exp: 2014-01-14→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.43 to $51.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Options are 100% vested.